| Document Date: 2012-01-05 07:37:15
Open Document File Size: 198,52 KBShare Result on Facebook
Company Johnson & Johnson / Beth Israel Deaconess Medical Center / Crucell Holland B.V. / / Country Netherlands / / Event Business Partnership / / Facility Ragon Institute of MGH / Walter Reed Army Institute of Research / Beth Israel Deaconess Medical Center / National Institute of Allergy / / IndustryTerm healthcare industry / online version / / MedicalCondition HIV infection / HIV / infection / / Organization Walter Reed Army Institute of Research / National Institute of Allergy and Infectious Diseases / Ragon Institute of MGH / MIT / Harvard / / Person Jaap Goudsmit / Karen Manson / / / Position Chief Scientific Officer / forward for HIV vaccine development / Private / Chief Scientific Officer / Crucell Holland B.V. Further analysis / / PublishedMedium the journal Nature / / Technology antibodies / / URL www.sec.gov / www.jnj.com / /
SocialTag |
CONTACTS: Karen Manson, Media +[removed]mobile) Promising Results of Novel Combination Vaccine Preclinical Study Provides Strong Rationale for HIV Vaccine Clinical Trials